These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 8853957)
1. Vasopressin and oxytocin receptors in the central nervous system. Barberis C; Tribollet E Crit Rev Neurobiol; 1996; 10(1):119-54. PubMed ID: 8853957 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor. Pierce ML; French JA; Murray TF Biomed Pharmacother; 2020 Jun; 126():110060. PubMed ID: 32145592 [TBL] [Abstract][Full Text] [Related]
3. Cross-talk among oxytocin and arginine-vasopressin receptors: Relevance for basic and clinical studies of the brain and periphery. Song Z; Albers HE Front Neuroendocrinol; 2018 Oct; 51():14-24. PubMed ID: 29054552 [TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacology of human vasopressin receptors. Thibonnier M; Conarty DM; Preston JA; Wilkins PL; Berti-Mattera LN; Mattera R Adv Exp Med Biol; 1998; 449():251-76. PubMed ID: 10026814 [TBL] [Abstract][Full Text] [Related]
5. Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family. Chini B; Mouillac B; Ala Y; Balestre MN; Cotte N; Trumpp-Kallmeyer S; Hoflack J; Elands J; Hibert M; Manning M Adv Exp Med Biol; 1995; 395():321-8. PubMed ID: 8713982 [TBL] [Abstract][Full Text] [Related]
6. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems. Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100 [TBL] [Abstract][Full Text] [Related]
7. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Manning M; Stoev S; Chini B; Durroux T; Mouillac B; Guillon G Prog Brain Res; 2008; 170():473-512. PubMed ID: 18655903 [TBL] [Abstract][Full Text] [Related]
8. Molecular evolution of ligand-binding specificity in the vasopressin/oxytocin receptor family. van Kesteren RE; Geraerts WP Ann N Y Acad Sci; 1998 May; 839():25-34. PubMed ID: 9629128 [No Abstract] [Full Text] [Related]
9. Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Postina R; Kojro E; Fahrenholz F Adv Exp Med Biol; 1998; 449():371-85. PubMed ID: 10026828 [TBL] [Abstract][Full Text] [Related]
10. Distribution of vasopressin and oxytocin binding sites in the brain and upper spinal cord of the common marmoset. Schorscher-Petcu A; Dupré A; Tribollet E Neurosci Lett; 2009 Sep; 461(3):217-22. PubMed ID: 19539696 [TBL] [Abstract][Full Text] [Related]
11. Cloning and functional characterization of the amphibian mesotocin receptor, a member of the oxytocin/vasopressin receptor superfamily. Akhundova A; Getmanova E; Gorbulev V; Carnazzi E; Eggena P; Fahrenholz F Eur J Biochem; 1996 May; 237(3):759-67. PubMed ID: 8647123 [TBL] [Abstract][Full Text] [Related]
12. Identification of agonist binding sites of vasopressin and oxytocin receptors. Mouillac B; Chini B; Balestre MN; Jard S; Barberis C; Manning M; Tribollet E; Trumpp-Kallmeyer S; Hoflack J; Elands J Adv Exp Med Biol; 1995; 395():301-10. PubMed ID: 8713980 [TBL] [Abstract][Full Text] [Related]
13. Increasing expression of oxytocin and vasopressin receptors in the equine conceptus between Days 10 and 16 of pregnancy. Budik S; Palm F; Walter I; Helmreich M; Aurich C Reprod Fertil Dev; 2012; 24(5):641-8. PubMed ID: 22697114 [TBL] [Abstract][Full Text] [Related]
14. Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin. Chini B; Mouillac B; Balestre MN; Trumpp-Kallmeyer S; Hoflack J; Hibert M; Andriolo M; Pupier S; Jard S; Barberis C FEBS Lett; 1996 Nov; 397(2-3):201-6. PubMed ID: 8955347 [TBL] [Abstract][Full Text] [Related]
15. Functions of vasopressin and oxytocin in bone mass regulation. Sun L; Tamma R; Yuen T; Colaianni G; Ji Y; Cuscito C; Bailey J; Dhawan S; Lu P; Calvano CD; Zhu LL; Zambonin CG; Di Benedetto A; Stachnik A; Liu P; Grano M; Colucci S; Davies TF; New MI; Zallone A; Zaidi M Proc Natl Acad Sci U S A; 2016 Jan; 113(1):164-9. PubMed ID: 26699482 [TBL] [Abstract][Full Text] [Related]
16. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells. Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400 [TBL] [Abstract][Full Text] [Related]
17. Effects of arginine vasopressin and oxytocin on glucagon release from clonal alpha-cell line In-R1-G9: involvement of V1b receptors. Yibchok-anun S; Hsu WH Life Sci; 1998; 63(21):1871-8. PubMed ID: 9825765 [TBL] [Abstract][Full Text] [Related]
18. Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy. Fuchs AR; Behrens O; Maschek H; Kupsch E; Einspanier A Hum Reprod Update; 1998; 4(5):594-604. PubMed ID: 10027613 [TBL] [Abstract][Full Text] [Related]
19. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors. Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974 [TBL] [Abstract][Full Text] [Related]
20. Ontogeny of oxytocin and vasopressin receptor binding in the lateral septum in prairie and montane voles. Wang Z; Young LJ Brain Res Dev Brain Res; 1997 Dec; 104(1-2):191-5. PubMed ID: 9466721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]